Evidence map›Paper›PMID 35610485›Full record

ArticleOncogene2022

Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.

Max A K Rätze, Thijs Koorman, Thijmen Sijnesael, Blessing Bassey-Archibong, Robert van de Ven, Lotte Enserink, Daan Visser, Sridevi Jaksani, Ignacio Viciano, Elvira R M Bakker and 10 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 5 countries.

Max A K Rätze *Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Thijs Koorman *Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-6064-3353
Thijmen SijnesaelDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-2248-9786
Blessing Bassey-ArchibongDepartment of Biology, McMaster University, Hamilton, ON, Canada.
Robert van de VenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Lotte EnserinkDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Daan VisserDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-1062-8745
Sridevi JaksaniDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Ignacio VicianoInstitute for Bioengineering of Catalonia (IBEC), the Barcelona Institute of Technology (BIST), Barcelona, Spain.
Elvira R M BakkerDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-3156-3725
François RichardLaboratory for Translational Breast Cancer Research, Katholieke Universiteit, Leuven, Belgium.ORCID http://orcid.org/0000-0003-4353-3619
Andrew TuttThe Breast Cancer Now Research Unit, King's College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-8715-2901
Lynda O'LearyBreast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
Amanda FitzpatrickBreast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
Pere Roca-CusachsInstitute for Bioengineering of Catalonia (IBEC), the Barcelona Institute of Technology (BIST), Barcelona, Spain.ORCID http://orcid.org/0000-0001-6947-961X
Paul J van DiestDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Christine DesmedtLaboratory for Translational Breast Cancer Research, Katholieke Universiteit, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5223-5579
Juliet M DanielDepartment of Biology, McMaster University, Hamilton, ON, Canada.
Clare M IsackeBreast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.ORCID http://orcid.org/0000-0002-9222-3345
Patrick W B DerksenDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. p.w.b.derksen@umcutrecht.nl.ORCID http://orcid.org/0000-0003-0732-7762
University Medical Center Utrecht · NLInstitute of Cancer Research · GBInstitute for Bioengineering of Catalonia · ESKU Leuven · BEMcMaster University · CAUtrecht University · NL

Funding

Medical Research Council MR/P001564/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35610485
PMCPMC9232389
OpenAlexW4281392802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.